-

Stockholder Alert - Robbins LLP Informs Investors of the Datavault AI Inc. Class Action 

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Datavault AI Inc. (NASDAQ: DVLT) securities between September 4, 2024 and October 30, 2025. Datavault AI is a data sciences technology company, owns and operates data management platforms with high computing capabilities in North America, Asia Pacific, Europe, and internationally.

Datavault was previously known as WiSA Technologies, Inc. On September 4, 2024, WiSA announced it had agreed to acquire the intellectual property of Data Vault Holdings, Inc. WiSA further announced that upon closing the acquisition, it intended to change its name to "Datavault AI Inc." The Company officially changed its name on February 13, 2025.

Why Was Datavault Sued?

The complaint alleges that defendants misled investors regarding its business prospects and failed to disclose that:

  1. defendants had overstated the economic value to Datavault AI of its various corporate partnerships with, inter alia, Burke, Scilex, and Nature’s Miracle;
  2. defendants had overstated the volume of trading activity on the Datavault Platform, which was in fact minimal;
  3. the Company’s undisclosed connections with Withrow, a convicted felon, when revealed, would cause Datavault AI to incur reputational harm; and
  4. as a result, defendants’ public statements were materially false and misleading at all relevant times.

Why Did DataVault AI's Stock Drop?

Plaintiff alleges that on October 31, 2025, Wolfpack Research published a short report concerning Datavault AI Inc. The report alleged, among other things, that Datavault was a “stock promotion” that relied on misleading press releases and “empty claims” concerning artificial intelligence, quantum computing, Web 3.0, and data monetization.

Wolfpack further alleged that Datavault's press releases were filled with promotional buzzwords that did not reflect the Company’s actual business operations. The report also questioned the activity on the Company’s blockchain marketplace, alleging that Datavault’s platform had virtually no trading activity. In addition, Wolfpack raised concerns regarding Datavault’s leadership and affiliations, including alleged connections involving a convicted felon.

On this news, Datavault AI’s stock price fell $0.49 per share, or 19.44%, to close at $2.03 per share on October 31, 2025.

Who May Be Eligible to Participate in the DVLT Class Action?

Investors who purchased or otherwise acquired DVLT securities between September 4, 2024 and October 30, 2025, may be eligible to participate in the proposed securities class action.

If you purchased DVLT shares during the Class Period and suffered losses, you may have rights under the federal securities laws.

What Is a Lead Plaintiff?

The lead plaintiff is a representative investor appointed by the court to act on behalf of other members of the proposed class and help direct the litigation.

Investors do not have to become lead plaintiff to potentially participate in any recovery obtained through the litigation.

Does it cost anything to participate?

No. Robbins LLP represents investors on a contingency fee basis. Investors never pay attorneys' fees or litigation expenses. If there is a recovery for shareholders, defendants pay fees and expenses.

Contact Robbins LLP

Investors seeking additional information about the Datavault AI Inc. securities class action may submit an inquiry, email attorney Aaron Dumas, Jr., or call (800) 350-6003.

About Robbins LLP

A recognized leader in shareholder rights litigation, Robbins LLP has helped restore more than $1 billion in value to shareholders, secured some of the largest recoveries in shareholder derivative litigation history, and achieved governance reforms at over 400 Fortune 1000 companies.

"Behind everything we do is the belief that companies should be governed responsibly, fiduciaries should be held accountable, and shareholders deserve transparency and fairness," said Brian J. Robbins, Founding Partner of Robbins LLP.

To be notified if a class action against Datavault AI Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Robbins LLP

NASDAQ:DVLT

Release Summary
Robbins LLP is Investigating Allegations that Datavault AI Inc. Misled Investors Regarding its Business Prospects
Release Versions
$Cashtags

Contacts

Aaron Dumas, Jr.
Robbins LLP
5060 Shoreham Pl., Ste. 300
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

Social Media Profiles
More News From Robbins LLP

Investor Alert: Robbins LLP Informs Investors of the Alarum Technologies Ltd. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of all persons and entities that purchased or otherwise acquired Alarum Technologies Ltd. (NASDAQ: ALAR) securities between March 20, 2025 and July 2, 2026 (the "Class Period"). Alarum contends to be global provider of web data collection solutions, empowering organizations to gain a competitive edge by streamlining the collection, extraction, and analysis of large-scale structured...

Shareholder Notice: Robbins LLP Informs Investors of the ARS Pharmaceuticals Inc. Class Action  

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs shareholders that a securities class action has been filed on behalf of all investors who purchased or otherwise acquired ARS Pharmaceuticals Inc. (NASDAQ: SPRY) securities between March 9, 2026 and June 24, 2026 (the "Class Period"). ARS is a clinical stage biopharmaceutical company focused on the development and commercialization of neffy for needle-free intranasal delivery of epinephrine for emergency treatment of Type 1 allergic reactions, inc...

Stockholder Alert: Robbins LLP Informs Investors of the Gildan Activewear Inc. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs investors that a securities class action has been filed on behalf of former HanesBrands shareholders who acquired common shares of Gildan Activewear Inc. (NYSE/TSE: GIL) in connection with the December 2025 cash-and-stock exchange through which Gildan acquired HanesBrands. Gildan is a global manufacturer of everyday basic apparel, including activewear, underwear and sock products. The lawsuit alleges that Gildan's Offering Materials contained mate...
Back to Newsroom